Chen Manqin, Chen Xinbin, Ling Huaxiang, Bai Chengwen, Chen Lihua, Zhong Lin, Gong Ping, Shi Fei
Department of Emergency, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China.
Zhuhai International Travel Healthcare Center, Port Clinic of Gongbei Customs District, Zhuhai, Guangdong, China.
Front Nephrol. 2024 Nov 6;4:1398386. doi: 10.3389/fneph.2024.1398386. eCollection 2024.
Fibrinogen plays a pivotal role in the inflammatory cascade and is intricately linked to the pathogenesis of sepsis. Nevertheless, its significance as a prognostic marker for sepsis-associated acute kidney injury (SA-AKI) remains uncertain. This study aimed to investigate the association between fibrinogen levels and 28-day mortality with sepsis-associated acute kidney injury.
The fibrinogen levels of patients admitted to the intensive care unit of Beth Israel Deaconess Medical Center between 2008 and 2019 were retrospectively assessed, and those diagnosed with SA-AKI were divided into low, middle and high fibrinogen level groups according to tertiles. Multivariate Cox proportional hazards model was used to assess the 28-day mortality risk of the SA-AKI patients.
A total of 3,479 patients with SA-AKI were included in the study. Fibrinogen demonstrated an independent association with 28-day mortality, yielding a hazard ratio (HR) of 0.961 (95% confidence interval [CI]: 0.923-0.999, = 0.0471). Notably, a non-linear relationship between fibrinogen levels and 28-day mortality was observed, with the threshold observed at approximately 1.6 g/l. The effect sizes and corresponding CIs below and above this threshold were 0.509 (0.367, 0.707) and 1.011 (0.961, 1.064), respectively. Specifically, the risk of mortality among SA-AKI patients decreased by 49.1% for every 1 g/l increment in fibrinogen, provided that fibrinogen levels were less than 1.6 g/l.
In patients with SA-AKI, a non-linear relationship was identified between fibrinogen levels and 28-day mortality. Particularly, when their fibrinogen levels were less than 1.6 g/l, a concomitant decrease in 28-day mortality was observed as fibrinogen levels increased.
纤维蛋白原在炎症级联反应中起关键作用,且与脓毒症的发病机制密切相关。然而,其作为脓毒症相关急性肾损伤(SA-AKI)预后标志物的意义仍不明确。本研究旨在探讨纤维蛋白原水平与脓毒症相关急性肾损伤患者28天死亡率之间的关联。
回顾性评估2008年至2019年期间入住贝斯以色列女执事医疗中心重症监护病房患者的纤维蛋白原水平,将诊断为SA-AKI的患者按三分位数分为低、中、高纤维蛋白原水平组。采用多变量Cox比例风险模型评估SA-AKI患者的28天死亡风险。
本研究共纳入3479例SA-AKI患者。纤维蛋白原与28天死亡率呈独立关联,风险比(HR)为0.961(95%置信区间[CI]:0.923 - 0.999,P = 0.0471)。值得注意的是,观察到纤维蛋白原水平与28天死亡率之间存在非线性关系,阈值约为1.6 g/l。该阈值以下和以上的效应大小及相应CI分别为0.509(0.367,0.707)和1.011(0.961,1.064)。具体而言,对于纤维蛋白原水平低于1.6 g/l的SA-AKI患者,纤维蛋白原每增加1 g/l,死亡风险降低49.1%。
在SA-AKI患者中,纤维蛋白原水平与28天死亡率之间存在非线性关系。特别是,当纤维蛋白原水平低于1.6 g/l时,随着纤维蛋白原水平升高,28天死亡率随之降低。